Bausch Health Companies Inc.
BHC.TO
TSX
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 7.64% | 3.12% | |||
| Total Other Revenue | 4.00% | 19.05% | |||
| Total Revenue | 7.60% | 3.28% | |||
| Cost of Revenue | 13.16% | -4.01% | |||
| Gross Profit | 5.45% | 6.39% | |||
| SG&A Expenses | 6.57% | 0.56% | |||
| Depreciation & Amortization | 11.46% | -5.95% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.00% | -2.35% | |||
| Operating Income | 2.63% | 29.66% | |||
| Income Before Tax | 97.85% | -512.66% | |||
| Income Tax Expenses | -28.57% | 7.69% | |||
| Earnings from Continuing Operations | 87.70% | -1,514.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 100.00% | 500.00% | |||
| Net Income | 89.68% | -1,553.85% | |||
| EBIT | 2.63% | 29.66% | |||
| EBITDA | 5.16% | 14.22% | |||
| EPS Basic | 89.37% | -1,550.91% | |||
| Normalized Basic EPS | -3.75% | 245.16% | |||
| EPS Diluted | 89.37% | -1,577.86% | |||
| Normalized Diluted EPS | -3.75% | 247.34% | |||
| Average Basic Shares Outstanding | -2.97% | 0.16% | |||
| Average Diluted Shares Outstanding | -2.97% | -0.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
